Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu; Wassim Abou-Kheir; Juan Juan Yin; Yung Sheng Chang; Ben Barrett; Florent Suau; Orla Casey; Wei Yu Chen; Lei Fang; Paul Hynes; Yao Yu Hsieh; Yen Nien Liu; Jiaoti Huang; Kathleen Kelly

doi:10.18632/oncotarget.26020

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei Yu Chen, Lei Fang, Paul Hynes, Yao Yu Hsieh, Yen Nien Liu, Jiaoti Huang, Kathleen Kelly

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

3 引文斯高帕斯（Scopus）

摘要

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

原文	英語
頁（從 - 到）	32403
頁數	1
期刊	Oncotarget
卷	9
發行號	64
DOIs	https://doi.org/10.18632/oncotarget.26020
出版狀態	已發佈 - 8月 17 2018

ASJC Scopus subject areas

腫瘤科

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.18632/oncotarget.26020

其它文件與鏈接

Link to publication in Scopus

引用此

Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J., & Kelly, K. (2018). Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. Oncotarget, 9(64), 32403. https://doi.org/10.18632/oncotarget.26020

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. / Siu, Man Kit; Abou-Kheir, Wassim; Yin, Juan Juan 等.
於: Oncotarget, 卷 9, 編號 64, 17.08.2018, p. 32403.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Siu, MK, Abou-Kheir, W, Yin, JJ, Chang, YS, Barrett, B, Suau, F, Casey, O, Chen, WY, Fang, L, Hynes, P, Hsieh, YY , Liu, YN, Huang, J & Kelly, K 2018, 'Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994', Oncotarget, 卷 9, 編號 64, 頁 32403. https://doi.org/10.18632/oncotarget.26020

@article{79bfee96310947239f191b500b85ea0b,

title = "Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994",

abstract = "This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.",

author = "Siu, {Man Kit} and Wassim Abou-Kheir and Yin, {Juan Juan} and Chang, {Yung Sheng} and Ben Barrett and Florent Suau and Orla Casey and Chen, {Wei Yu} and Lei Fang and Paul Hynes and Hsieh, {Yao Yu} and Liu, {Yen Nien} and Jiaoti Huang and Kathleen Kelly",

note = "Publisher Copyright: {\textcopyright} 2018, Siu et al.",

year = "2018",

month = aug,

day = "17",

doi = "10.18632/oncotarget.26020",

language = "English",

volume = "9",

pages = "32403",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "64",

}

TY - JOUR

T1 - Correction

T2 - Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

AU - Siu, Man Kit

AU - Abou-Kheir, Wassim

AU - Yin, Juan Juan

AU - Chang, Yung Sheng

AU - Barrett, Ben

AU - Suau, Florent

AU - Casey, Orla

AU - Chen, Wei Yu

AU - Fang, Lei

AU - Hynes, Paul

AU - Hsieh, Yao Yu

AU - Liu, Yen Nien

AU - Huang, Jiaoti

AU - Kelly, Kathleen

PY - 2018/8/17

Y1 - 2018/8/17

N2 - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

AB - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=85051835232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051835232&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26020

DO - 10.18632/oncotarget.26020

M3 - Comment/debate

AN - SCOPUS:85051835232

SN - 1949-2553

VL - 9

SP - 32403

JO - Oncotarget

JF - Oncotarget

IS - 64

ER -

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

摘要

ASJC Scopus subject areas

UN SDG

存取文件

其它文件與鏈接

指紋

引用此